Viaderma is selling at 0.0094 as of the 11th of December 2024; that is 4.44 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0092. Viaderma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 137.32 K outstanding shares. More on Viaderma
Viaderma [VDRM] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 82.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viaderma's market, we take the total number of its shares issued and multiply it by Viaderma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Viaderma conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 137.32 K outstanding shares.
Viaderma currently holds about 13.08 K in cash with (167.36 K) of positive cash flow from operations.
Check Viaderma Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Viaderma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Stock Tickers Now
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Other Information on Investing in Viaderma Pink Sheet
Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.